Skip to main content

Table 3 Comparison of non-CP and CP group with average length of stay (ALOS)

From: Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation

Variable Non-Clinical Pathway (n = 98) Clinical Pathway (n = 95) Pvalue
Average length of stay in days (LOS) 7.31 ± 2.75 5.83 ± 1.92 <0.001#
*Median LOS in days 7 (7–9) 5 (4–7) <0.001ψ
  1. # = independent t test, *Median IQR (25th-75th), ψ = Mann Whitney U test, Significant level P <0.05.